11.4 Diagnostic Toxicology: Acid-Base Analysis, Gaps, ECG Intervals, and Drug Testing

In the management of the poisoned patient, general clinical laboratory testing, 12-lead electrocardiography, and targeted drug assays provide indispensable diagnostic and prognostic data. Rather than relying on non-specific clinical impressions, the Specialist in Poison Information (CSPI) and clinical toxicologist utilize rigorous mathematical models—such as the serum anion gap, delta-delta ratio, and osmolal gap—alongside precise electrophysiological measurements to identify occult toxins, assess life-threatening cellular toxicity, and guide antidotal interventions.

---

High Anion Gap Metabolic Acidosis (HAGMA) in Toxicology

The serum anion gap measures the balance between routinely measured serum cations and anions, serving as a vital biochemical screening tool for unmeasured endogenous and exogenous toxic acids.

Serum Anion Gap Formula:  AG = [Na+] - ([Cl-] + [HCO3-])
Normal Reference Range:    8 to 12 mEq/L (lab specific, up to 14 mEq/L)
Correction for Albumin:   Adjusted AG = Observed AG + 2.5 * (4.0 - [Albumin in g/dL])

Because serum albumin accounts for the majority of unmeasured negative charges under normal physiological conditions, severe hypoalbuminemia artificially depresses the baseline anion gap. For every 1.0 g/dL drop in serum albumin below 4.0 g/dL, the baseline anion gap falls by approximately 2.5 mEq/L. Failing to correct for hypoalbuminemia can cause a clinician to miss a significant accumulation of toxic anions.

The Modern Toxicological Mnemonic: GOLD MARK

While the historical mnemonic MUDPILES is widely taught, modern clinical toxicology relies on the GOLD MARK framework, which accounts for contemporary toxicological and metabolic etiologies:

The Delta-Delta (Δ - Δ) Ratio: Decoding Mixed Acid-Base Disorders

In complex toxicological presentations, a patient may suffer from multiple concurrent acid-base derangements. The Delta-Delta (Δ AG / Δ HCO₃⁻) ratio compares the excess anion gap above normal to the deficit in serum bicarbonate below normal:

$\text{Delta-Delta Ratio } (\Delta - \Delta) = \frac{\Delta AG}{\Delta HCO_3^-} = \frac{\text{Observed } AG - 12}{24 - [HCO_3^-]}$

• Ratio Between 1.0 and 2.0 (Pure HAGMA): For every 1 mEq/L increase in unmeasured toxic anions, exactly 1 mEq/L of bicarbonate is consumed in buffering. Typical of pure diabetic ketoacidosis or early, uncomplicated toxic alcohol ingestions.
• Ratio < 1.0 (typically < 0.4 to 0.8) (Mixed HAGMA + Normal Anion Gap Metabolic Acidosis): The drop in bicarbonate is disproportionately greater than the rise in the anion gap. Common in toluene / volatile solvent abuse (hippuric acid excretion causes hyperchloremic NAGMA), toxic diarrhea, or underlying renal tubular acidosis.
• Ratio > 2.0 (Mixed HAGMA + Metabolic Alkalosis): The serum bicarbonate is substantially higher than predicted for the degree of anion gap elevation. Classically observed in acute salicylate poisoning where persistent, violent vomiting causes hydrochloric acid and gastric volume loss (metabolic alkalosis) superimposed upon severe salicylate-induced high anion gap acidosis.

---

The Serum Osmolal Gap in Toxicology

The serum osmolal gap evaluates the presence of low-molecular-weight, osmotically active xenobiotics circulating in the bloodstream before significant metabolic degradation has occurred.

Calculated Serum Osmolality Formula (Conventional Units in mg/dL):
Calculated Osm = 2 * [Na+] + (Glucose / 18) + (BUN / 2.8) + (Ethanol / 4.6)

Serum Osmolal Gap Formula:
Osmolal Gap = Measured Serum Osmolality - Calculated Serum Osmolality
Normal Reference Range:  -10 to +10 mOsm/kg (clinical suspicion raised if > 10–14 mOsm/kg)

Critical Analytical Pitfall: Freezing Point Depression vs. Vapor Pressure

When ordering measured serum osmolality for suspected toxic alcohol ingestions, the laboratory must use a freezing point depression osmometer. Volatile alcohols (methanol, ethanol, isopropanol) vaporize into the gas phase during vapor pressure osmometry, resulting in a falsely normal measured osmolality and a completely masked, falsely normal osmolal gap.

The Reciprocal 'Hourglass' Phenomenon: Osmolal Gap vs. Anion Gap

Understanding the temporal evolution of toxic alcohol metabolism is one of the most critical concepts in clinical toxicology:

Early Post-Ingestion (0–4 Hours):    HIGH Osmolal Gap  |  NORMAL Anion Gap  (Parent alcohol intact)
Intermediate Phase (6–12 Hours):     FALLING Osm Gap   |  RISING Anion Gap  (Metabolism underway)
Late Presentation (> 12–24 Hours):   NORMAL Osm Gap   |  MASSIVE Anion Gap (Parent alcohol exhausted)

• Early Phase: Immediately following ingestion of methanol or ethylene glycol, the parent compound circulates unmetabolized in high concentrations. Because the parent alcohols are electrically neutral, the osmolal gap is markedly elevated, while the anion gap remains completely normal.
• Metabolic Conversion: Hepatic alcohol dehydrogenase (ADH) and aldehyde dehydrogenase metabolize the parent alcohols into small organic acids (glycolic/oxalic acid for ethylene glycol; formic acid for methanol).
• Late Phase: As parent molecules are consumed, the osmolal gap closes back into the normal range, while unmeasured anionic metabolites accumulate, driving an enormous high anion gap metabolic acidosis.

Clinical Triage Warning: A completely normal osmolal gap in a patient presenting 18 hours after an ingestion does NOT rule out ethylene glycol or methanol toxicity. By that time, all parent alcohol has been metabolized into lethal organic acids, and the patient will present in profound metabolic acidosis with renal failure or optic injury.

The Isopropanol Exception: Ketosis Without Acidosis

Isopropanol (rubbing alcohol) is metabolized by alcohol dehydrogenase into acetone, which is a ketone rather than an acid. Consequently, isopropanol toxicity presents with an elevated osmolal gap, ketonemia, and ketonuria WITHOUT metabolic acidosis (normal anion gap and normal serum bicarbonate), accompanied by marked central nervous system depression and hemorrhagic gastritis.

---

Toxicology Electrocardiography (ECG)

The 12-lead ECG is an instantaneous, non-invasive window into myocardial ion channel function, alerting clinicians to life-threatening cardiotoxicity before overt dysrhythmias develop.

1. Myocardial Sodium Channel Blockade (Phase 0 Depolarization)

Numerous xenobiotics block cardiac fast voltage-gated sodium channels (Nav1.5), slowing Phase 0 of the cardiac action potential and prolonging intraventricular conduction.

• Offending Agents: Tricyclic antidepressants (TCAs: amitriptyline, nortriptyline), Type Ia and Ic antiarrhythmics (quinidine, procainamide, flecainide), diphenhydramine, cocaine, propoxyphene, chloroquine, and carbamazepine.
• Electrocardiographic Hallmarks:
  • QRS Interval Widening: Measured in the limb leads.
    • QRS > 100 ms: Associated with an approximate 33% risk of generalized seizures.
    • QRS > 160 ms: Associated with an approximate 50% risk of life-threatening ventricular dysrhythmias (monomorphic ventricular tachycardia, ventricular fibrillation).
  • Terminal 40 ms QRS Axis Shift in Lead aVR: Because the right bundle branch and basal right ventricular septum are particularly sensitive to conduction delay, the terminal electrical vector shifts rightward and superiorly into lead aVR:
    • Prominent terminal R wave in aVR ≥ 3 mm.
    • R/S ratio in aVR > 0.7.
• Therapeutic Intervention: Immediate administration of hypertonic sodium bicarbonate (1 to 2 mEq/kg IV push bolus), which acts via two distinct mechanisms: (1) flooding extracellular space with high sodium concentrations ([Na⁺] ≈ 1000 mEq/L in 8.4% solutions) to overcome competitive channel block, and (2) systemic alkalinization (targeting blood pH 7.45 to 7.55), which shifts the drug into an un-ionized conformation, detaching it from the sodium channel binding site.

2. Potassium Channel (IKr) Blockade and QTc Prolongation

Xenobiotics that block rapid delayed rectifier potassium channels (IKr, encoded by the hERG gene) impair Phase 3 myocardial repolarization, manifesting as marked QTc interval prolongation.

• Offending Agents: Methadone, citalopram, escitalopram, antipsychotics (haloperidol, ziprasidone, quetiapine), sotalol, quinolones, and macrolides.
• Clinical Thresholds: QTc intervals > 500 ms (calculated using Bazett's formula or Fridericia's correction) substantially increase the risk of degenerating into Torsades de Pointes (TdP) and ventricular fibrillation.
• Management: Correct hypokalemia (maintain serum K⁺ > 4.0 to 4.5 mEq/L) and hypomagnesemia (Mg²⁺ > 2.0 mg/dL). For active TdP or recurrent pauses, administer intravenous magnesium sulfate (2 g IV over 1–2 minutes) and initiate overdrive transvenous or pharmacological (isoproterenol) pacing to maintain heart rate > 90 to 100 bpm.

---

Urine Drug Screens (UDS): Immunoassays, False-Positives, and Blind Spots

Point-of-care and laboratory-based urine drug screens rely on immunoassays such as EMIT, CEDIA, and KIMS. Antibodies in the reagent are engineered to bind a specific parent drug or major metabolite. Because these antibodies rely on structural shape-matching, they are plagued by cross-reactivity and false-negative 'blind spots'.

1. Common False-Positive Cross-Reactions

2. The Critical Synthetic Blind Spot: False Negatives

A critical tenet of clinical toxicology is that a negative routine urine drug screen never excludes severe opioid or sedative-hypnotic poisoning:

• The Opioid Immunoassay: Calibrated specifically against morphine. It reliably detects natural opiates (morphine, codeine) and the semi-synthetic heroin metabolite (6-monoacetylmorphine). However, it CANNOT DETECT SYNTHETIC OPIOIDS: fentanyl, fentanyl analogues, methadone, buprenorphine, tramadol, or meperidine. A patient dying of a fatal fentanyl overdose will have a completely negative routine opiate urine drug screen!
• The Benzodiazepine Immunoassay: Calibrated against oxazepam. It reliably detects drugs that metabolize to oxazepam (diazepam, chlordiazepoxide, temazepam). It frequently misses lorazepam, clonazepam, alprazolam, and novel designer benzodiazepines because their metabolites lack sufficient cross-reactivity with the antibody.
• Novel Psychoactive Substances (NPS): Synthetic cathinones ('bath salts'), synthetic cannabinoids ('K2/Spice'), hallucinogenic phenethylamines (2C-I, NBOMe), and xylazine are completely invisible on standard urine drug immunoassays, requiring specialized gas chromatography-mass spectrometry (GC-MS) or liquid chromatography-tandem mass spectrometry (LC-MS/MS) for confirmation.

---

Poison Center Case Scenario: The Acidotic Comatose Patient

A 45-year-old male with a history of alcohol use disorder is found unresponsive on the floor of his garage and brought to the emergency department. On arrival, he is comatose (GCS 6), intubated for airway protection, and breathing on a mechanical ventilator. Vital signs: blood pressure 102/60 mmHg, heart rate 108 bpm, temperature 36.2°C. The 12-lead ECG reveals a normal sinus tachycardia with QRS duration 88 ms and QTc 440 ms.

Laboratory Data Received

• Electrolytes & Chemistries: Sodium 140 mEq/L, Potassium 4.8 mEq/L, Chloride 98 mEq/L, Bicarbonate 10 mEq/L, BUN 14 mg/dL, Serum Creatinine 1.8 mg/dL, Glucose 90 mg/dL, Serum Albumin 4.0 g/dL.
• Blood Gas: pH 7.14, pCO₂ 28 mmHg, pO₂ 95 mmHg, HCO₃⁻ 9.5 mEq/L.
• Toxicology Screen: Ethanol level 0 mg/dL. Routine urine drug screen is completely negative.
• Serum Osmolality (by Freezing Point Depression): 335 mOsm/kg.

Specialist in Poison Information Consultation Analysis

1. High Anion Gap Calculation: $AG = [Na^+] - ([Cl^-] + [HCO_3^-]) = 140 - (98 + 10) = \mathbf{32\text{ mEq/L}}$ This represents a severe High Anion Gap Metabolic Acidosis (normal 8–12 mEq/L).
2. Delta-Delta (Δ - Δ) Analysis: $\Delta AG = 32 - 12 = 20$ $\Delta HCO_3^- = 24 - 10 = 14$ $\Delta - \Delta = 20 / 14 = \mathbf{1.43}$ A ratio between 1.0 and 2.0 confirms a pure, unmixed high anion gap metabolic acidosis.
3. Calculated Osmolality and Osmolal Gap: $\text{Calculated Osm} = 2(140) + \frac{90}{18} + \frac{14}{2.8} + 0 = 280 + 5 + 5 = 290\text{ mOsm/kg}$ $\text{Osmolal Gap} = 335 - 290 = \mathbf{45\text{ mOsm/kg}}$ An osmolal gap of 45 mOsm/kg (normal < 10 mOsm/kg) confirms the presence of a high concentration of an unmeasured, low-molecular-weight osmotically active toxic alcohol.
4. Diagnostic Synthesis and Immediate Interventions: The combination of a massive Osmolal Gap (45 mOsm/kg) and a massive High Anion Gap Metabolic Acidosis (32 mEq/L) with acute renal impairment (1.8 mg/dL) points directly to severe ethylene glycol poisoning (or methanol). The CSPI directs the immediate administration of fomepizole (15 mg/kg IV loading dose), urgent emergent hemodialysis, systemic intravenous sodium bicarbonate infusion, and intravenous thiamine and pyridoxine supplementation.

Electrolyte Patterns and Choosing the Right Tests

Two official objectives ask the specialist to name the causative agent from an abnormal electrolyte panel and to decide which laboratory or ancillary tests should be obtained. Both are pattern-recognition tasks.

Electrolyte Clues

Blood Findings That Point to an Agent

Two more official objectives ask the specialist to name the likely agent from a coagulopathy and to recognize the methemoglobinemia syndrome.

Choosing Tests Rather Than Ordering Everything

Ordering principle: request a test when the result will change what you do in the next few hours. A confirmatory comprehensive drug screen almost never meets that standard; an acetaminophen level, a blood gas, an anion gap, and an ECG almost always do.